PAVmed
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of PAVmed generated cash of -$52,036,000, which is more than the previous year. Cash used in financing activities reached the amount of $31,173,000 last year. Net change in cash is therefore -$20,105,000.
Cash Flow
| 2014 | -60.27K | 0 | 1.73M |
|---|---|---|---|
| 2015 | -1.24M | 0 | 1.17M |
| 2016 | -4.45M | -21.79K | 4.29M |
| 2017 | -6.60M | -5.30K | 7.56M |
| 2018 | -8.78M | -26.60K | 15.50M |
| 2019 | -13.35M | -27.20K | 11.38M |
| 2020 | -21.91M | -55K | 33.00M |
| 2021 | -40.59M | -3.71M | 104.30M |
| 2022 | -70.98M | -4.74M | 38.21M |
| 2023 | -52.03M | 758K | 31.17M |
PAVMZ Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 39.74M | 77.25M | 17.25M | 6.21M | 8.22M | 1.53M | 585.68K | 767.26K | 839.07K | 0 |
Operating activities | ||||||||||
Net income | -64.17M | -103.23M | -56.12M | -35.88M | -17.26M | -18.17M | -9.51M | -5.65M | -1.77M | -548.76K |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 2.93M | 2.45M | 226K | 23K | 14.22K | 9.79K | 7.11K | 3.79K | 0 | 0 |
Stock-based compensation expense | 11.13M | 19.53M | 15.00M | 2.04M | 1.57M | 1.22M | 1.04M | 747.36K | 333.33K | 400K |
| Deferred income tax benefit | 11.13M | 19.53M | 15.00M | 2.04M | 1.57M | 1.22M | 1.04M | 747.36K | 333.33K | 400K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -44K | 183K | -200K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | -918K | -742K | 174K | 501K | 613.28K | 872.11K | -85.00K | 877.59K | 100.57K | 0 |
Cash generated by operating activities | -52.03M | -70.98M | -40.59M | -21.91M | -13.35M | -8.78M | -6.60M | -4.45M | -1.24M | -60.27K |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -242K | -1.54M | -1.46M | -55K | -27.20K | -26.60K | -5.30K | -21.79K | 0 | 0 |
Acquisitions Net | 0 | -3.2M | -2.24M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 758K | -4.74M | -3.71M | -55K | -27.20K | -26.60K | -5.30K | -21.79K | 0 | 0 |
Financing activities | ||||||||||
Common Stock Issued | 1.81M | 1.88M | 119.27M | 16.03M | 5.41M | 4.41M | 71.89K | 5.3M | 1.25M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | -7.09K | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | -366K | 0 | 357K | 0 | 16.43M | 0 | 0 | 0 | 0 |
Repayments of term debt | 9.92M | 35.22M | -14.97M | -600K | 5.93M | -5M | 4.84M | 0 | 0 | 0 |
Cash used in financing activities | 31.17M | 38.21M | 104.30M | 33.00M | 11.38M | 15.50M | 7.56M | 4.29M | 1.17M | 1.73M |
Net Change In Cash | -20.10M | -37.51M | 60.00M | 11.03M | -2.00M | 6.68M | 949.34K | -181.58K | -71.80K | 1.67M |
Cash at end of period | 19.63M | 39.74M | 77.25M | 17.25M | 6.21M | 8.22M | 1.53M | 585.68K | 767.26K | 1.67M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |